Fig. 6

DRD1 antagonist and IFN-beta siRNA reversed effects of A68930 on neurological outcome and brain water content after ICH. Garcia test score (a), left forelimb placement (b), and brain water content (c) at 24 h after ICH. ^**p < 0.01 versus sham; ^#p < 0.05, ^##p < 0.01 versus vehicle; ^$p < 0.05, ^$$p < 0.01 versus A68930 group; ^&p < 0.05 versus scramble siRNA group